المؤلفون: Hurwitz M; Department of Radiation Oncology, Thomas Jefferson University., Buscombe JR; Cambridge University Hospitals, Cambridge, UK., Jacene HA; Dana-Farber Cancer Institute.; Brigham and Women's Hospital, Boston, MA., Klitzke AK; Roswell Park Comprehensive Cancer Center., Lamonica D; Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY., Lu Y; MD Anderson Cancer Center., Pryma DA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Rohren EM; Baylor College of Medicine, Houston., Speer TW; Carris Health Cancer Center, Willmar, MN., Subramaniam RM; University of Otago, Dunedin, New Zealand., Thompson HM; The Permanente Medical Group, Sacramento, CA., Tomblyn MB; Loyola University Stritch School of Medicine, University of Loyola, Maywood, IL., Wong WW; Mayo Clinic Arizona, Phoenix, AZ., Xiao Y; Department of Radiation Oncology, University of Pennsylvania., Banks KP; San Antonio Uniformed Services Health Education Consortium.; Brooke Army Medical Center, Fort Sam Houston, TX., Brown RKJ; University of Michigan, Ann Arbor, MI.

المصدر: American journal of clinical oncology [Am J Clin Oncol] 2020 Aug; Vol. 43 (8), pp. 539-544.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Bone Neoplasms/*drug therapy , Bone Neoplasms/*radiotherapy , Radium/*therapeutic use, Combined Modality Therapy ; Humans ; Radioisotopes/therapeutic use